Panel-based NGS has gained popularity for the ability to simultaneously test multiple genes, including BRAF, for both V600E and non-V600E mutations, which is more cost-effective than sequential single-gene assays and uses relatively little tumor tissue39,40. This evidence concerns the gene BRAF and neoplasm.